TZELEPI VASILIKI, Associate Professor
Sector: Division of Clinical Laboratories
Clinic/Laboratory: Department of Pathology
Knowledge Subject: Pathology
Research Area: Carcinogenesis, Prostate Cancer, Epigenetics
Department of Pathology, University Hospital of Patras, 2nd floor
+302613604082 btzelepi@upatras.gr
Office hours
Monday and Wednesday, 13:00-14:00
Undergraduate Courses
- Pathology I (Semester: 4th)
- Pathology II (Semester: 5th)
- Pathology (Clinical Training) (Semester: 11th & 12th)
Selected Publications
Aparicio A, Tzelepi V, Araujo JC, Guo CC, Troncoso P, Logothetis CJ, Navone NM, Maity SN. Neuroendocrine prostate cancer xenografts with large-cell and small-cell features derived from a single patient’s tumor: Morphological, immunohistochemical, and gene expression profiles. Prostate 2010, 71: 846-856, 2010
Tzelepi V, Karlou M, Wen S, Hoang A, Logothetis C, Troncoso P, Efstathiou E. Expression of hedgehog pathway components in prostate carcinoma microenvironment: shifting the balance towards autocrine signaling. Histopathology 58:1037-1047, 2011
Tzelepi V, Efstathiou E, Wen S, Troncoso P, Karlou M, Pettaway CA, Pisters LL, Hoang A, Logothetis CJ, Pagliaro LC. Persistent, biologically meaningful prostate cancer after one year of androgen ablation and docetaxel treatment. J Clin Oncol 29:2574-2581, 2011
Tzelepi V, Zhang J, Lu JF, Kleb BN, Wu G, Hoang A, Efstathiou E, Sircar K, Navone N, Troncoso P, Liang SL, Logothetis CJ, Maity SN, Aparicio AM. Modeling a lethal prostate cancer variant with small cell features. Clin Cancer Res 18:666-677, 2012
Aparicio A, Tzelepi V. Neuroendocrine (Small-Cell) Carcinomas: Why They Teach Us Essential Lessons About Prostate Cancer. Oncology (Williston Park). 28(10), 2014
Tzelepi V. Editorial: Personalized cancer treatment. Curr Mol Pharmacol 7:2-3, 2014
Tzelepi V, Logotheti S, Efstathiou E, Troncoso P, Aparicio A. Sakellakis M, Hoang A, Perimenis P, Melachrinou M, Logothetis C, Zolota V. Epigenetics and Prostate Cancer: Defining the Timing of DNA Methyltransferase Deregulation During Prostate Cancer Progression. Pathology 52:218-227, 2020
Tzelepi V, Grypari IM, Logotheti S, Kontogiannis S, Kallidonis P, Melachrinou M, Zolota V. Contemporary Grading of Prostate Cancer: The Impact of Grading Criteria and the Significance of the Amount of Intraductal Carcinoma. Cancers (Basel) 29;13(21):5454, 2021
Grypari IM, Zolota V, Tzelepi V. Radical or Not-So-Radical Prostatectomy: Do Surgical Margins Matter? Cancers (Basel). 21;14(1):13, 2021
Milidaki F-T, Sakellaraki P, Papakonstantinou E, Zolota V, Tzelepi V. Molecular pathways in colorectal cancer. Achaiki Iatriki 40 (4):1-14, 2021
Grypari IM, Logotheti S, Zolota V, Troncoso P, Efstathiou E, Bravou V, Melachrinou M, Logothetis C, Tzelepi V. The protein arginine methyltransferases (PRMTs) PRMT1 and CARM1 as candidate epigenetic drivers in prostate cancer progression. Medicine (Baltimore). 10;100(36):e27094, 2021
Destouni AC, Lazaris M, Tzelepi V. Cribriform Patterned Lesions in the Prostate Gland with Emphasis on Differential Diagnosis and Clinical Significance Cancers 14 (13), 3041, 2022
Soundararajan R, Viscuse P, Pilie P, Liu J, Logotheti S, Fernández CL, Lorenzini D, Hoang A, Lu W, Solis Soto LM, Wistuba II, Xu M, Song X, Shepherd PDA, Navone NM, R. Tidwell SS, Lozano G, Logothetis C, Zhang J, Long JP, Estecio MR, Tzelepi V, Aparicio A Genotype-to-Phenotype Associations in the Aggressive Variant Prostate Cancer Molecular Profile (AVPC-m) Components Cancers 14 (13), 3233, 2022
Grypari IM, Pappa I, Papastergiou T, Zolota V, Bravou V, Melachrinou M, Megalooikonomou V, Tzelepi V. Elucidating the role of PRMTs in prostate cancer using open access databases and a patient cohort dataset. Histology and Histopathology, 18513, 2022
Selected Presentations
‘Health Promotion- History of MDACC- Overview of Carcinogenesis and Prostate Cancer’ Transylvania University, November, 2, 2010, Lexington, KY, USA
‘Slide Seminar in GYN Pathology’ Ioannina University Courses in Pathology, 31 May - 3 June 2011, Ioannina, Greece
‘Histochemical and immunohistochemical markers for testicular tumours’ 2014 Histopathology Study Day, 29 April, 2014 Galway, Ireland
‘Interesting cases in neoplastic endometrial and ovarian pathology’ Ioannina University Courses in Pathology, Gynecological Pathology-Oncology. Slide Seminar III: Pitfalls in GΥΝ Pathology – Oncology. 13 April, 2019, Ioannina, Greece
‘From tissue analysis to clinical phenotype’ 14th Update on the Management of GU Malignancies, 1 November 2019, Houston, TX, USA